Filing Details
- Accession Number:
- 0001437749-21-011553
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-10 13:00:00
- Reporting Period:
- 2021-05-06
- Accepted Time:
- 2021-05-10 17:05:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
72444 | Vaxart Inc. | VXRT | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1652203 | Wouter Latour | C/O Vaxart, Inc. 170 Harbor Way, Suite 300 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-06 | 100,000 | $1.70 | 100,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-06 | 100,000 | $6.54 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-05-07 | 100,000 | $1.70 | 100,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-07 | 100,000 | $7.13 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-05-06 | 100,000 | $0.00 | 100,000 | $1.70 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-05-07 | 100,000 | $0.00 | 100,000 | $1.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
800,000 | 2030-03-23 | No | 4 | M | Direct | |
700,000 | 2030-03-23 | No | 4 | M | Direct |
Footnotes
- 31.25% of the shares subject to this stock option vested on June 8, 2020, the grant date, with the remaining 68.75% vesting in 22 equal monthly installments on the first day of each calendar month thereafter, such that the option shall be fully vested on April 1, 2022.